Predictors of retention with abatacept in patients who have failed one or more biologic agents: results from the international, real-world ACTION study

被引：0
|
作者：
Nuesslein, H. [1 ]
Alten, R. [2 ]
Galeazzi, M. [3 ]
Lorenz, H. [4 ]
Boumpas, D. [5 ,6 ]
Nurmohamed, M. [7 ]
Bensen, W. [8 ,9 ]
Burmester, G. [10 ]
Peter, H. [11 ]
Rainer, F. [12 ]
Pavelka, K. [13 ]
Chartier, M. [14 ]
Poncet, C. [15 ]
Rauch, C. [16 ]
LeBars, M. [17 ]
机构：
[1] Rheumatol Schwerpunktpraxis, Nurnberg, Germany
[2] Charite, Schlosspk Klin, Akad Lehrkrankenhaus, D-13353 Berlin, Germany
[3] Univ Siena, Siena, Italy
[4] Univ Klinikum Heidelberg, Med Klin 5, Sekt Rheumatol, Heidelberg, Germany
[5] Univ Crete, Iraklion, Crete, Greece
[6] FORTH, IMBB, Iraklion, Crete, Greece
[7] Vrije Univ Amsterdam, Med Ctr, Jan van Breeman Res Inst, Amsterdam, Netherlands
[8] St Josephs Hosp, Hamilton, ON, Canada
[9] McMaster Univ, Hamilton, ON, Canada
[10] Charite, Med Klin Schwerpunkt Rheumatol & Klin Immunol, D-13353 Berlin, Germany
[11] Univ Freiburg Klinikum, Freiburg, Germany
[12] Hosp Barmherzige Brueder, Graz, Austria
[13] Inst Rheumatol, Prague, Czech Republic
[14] Chiltern Int, Neuilly, France
[15] Docs Int, Sevres, France
[16] Bristol Myers Squibb, Munich, Germany
[17] Bristol Myers Squibb, Rueil Malmaison, France
来源：
ZEITSCHRIFT FUR RHEUMATOLOGIE | 2013年 / 72卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：108 / 108
页数：1
相关论文
共 50 条
  • [1] PREDICTORS OF RETENTION WITH ABATACEPT IN PATIENTS WHO HAVE FAILED ONE OR MORE BIOLOGIC AGENTS: RESULTS FROM THE INTERNATIONAL, REAL-WORLD ACTION STUDY
    Nuesslein, Hubert
    Alten, Rieke
    Galeazzi, Maurizio
    Lorenz, Hannes M.
    Nurmohamed, Michael T.
    Bensen, William
    Burmester, Gerd R.
    Peter, Hans-Hartmut
    Pavelka, Karel
    Chartier, Melanie
    Poncet, Coralie
    Rauch, Christiane
    Le Bars, Manuela
    [J]. RHEUMATOLOGY, 2014, 53 : 94 - 95
  • [2] PREDICTORS OF RETENTION WITH ABATACEPT IN PATIENTS WHO HAVE FAILED ONE OR MORE BIOLOGIC AGENTS: RESULTS FROM THE INTERNATIONAL, REAL-WORLD ACTION STUDY
    Nuesslein, H.
    Alten, R.
    Galeazzi, M.
    Lorenz, H. M.
    Boumpas, D.
    Nurmohamed, M. T.
    Bensen, W. G.
    Burmester, G. R.
    Peter, H. -H.
    Rainer, F.
    Pavelka, K.
    Chartier, M.
    Poncet, C.
    Rauch, C.
    Le Bars, M.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 616 - 616
  • [3] Prognostic Factors for IV Abatacept Retention in Patients Who Have Received at Least One Prior Biologic Agent: 2-Year Results from a Prospective, International, Real-World Study
    Nuesslein, H.
    Alten, R.
    Galeazzi, M.
    Lorenz, H. M.
    Nurmohamed, M. T.
    Bensen, W. G.
    Burmester, Gerd
    Peter, H-H
    Peichl, P.
    Pavelka, K.
    Chartier, M.
    Poncet, C.
    Rauch, C.
    Le Bars, M.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S1087 - S1088
  • [4] PROGNOSTIC FACTORS FOR INTRAVENOUS ABATACEPT RETENTION IN PATIENTS WHO HAVE RECEIVED AT LEAST ONE PRIOR BIOLOGIC AGENT: 2-YEAR RESULTS FROM A PROSPECTIVE, INTERNATIONAL, REAL-WORLD STUDY
    Nuesslein, Hubert
    Alten, Rieke
    Galeazzi, Mauro
    Lorenz, Hanns-Martin
    Nurmohamed, Michael T.
    Bensen, William G.
    Burmester, Gerd R.
    Peter, Hans-Hartmut
    Peichl, Peter
    Pavelka, Karel
    Chartier, Melanie
    Poncet, Coralie
    Rauch, Christiane
    Le Bars, Manuela
    [J]. RHEUMATOLOGY, 2015, 54 : 77 - 78
  • [5] Predictors of abatacept retention over 2 years in patients with rheumatoid arthritis: results from the real-world ACTION study
    Alten, Rieke
    Mariette, Xavier
    Lorenz, Hanns-Martin
    Nuesslein, Hubert
    Galeazzi, Mauro
    Navarro, Federico
    Chartier, Melanie
    Heitzmann, Julia
    Poncet, Coralie
    Rauch, Christiane
    Le Bars, Manuela
    [J]. CLINICAL RHEUMATOLOGY, 2019, 38 (05) : 1413 - 1424
  • [6] Predictors of abatacept retention over 2 years in patients with rheumatoid arthritis: results from the real-world ACTION study
    Rieke Alten
    Xavier Mariette
    Hanns-Martin Lorenz
    Hubert Nüßlein
    Mauro Galeazzi
    Federico Navarro
    Melanie Chartier
    Julia Heitzmann
    Coralie Poncet
    Christiane Rauch
    Manuela Le Bars
    [J]. Clinical Rheumatology, 2019, 38 : 1413 - 1424
  • [7] Correction to: Predictors of abatacept retention over 2 years in patients with rheumatoid arthritis: results from the real-world ACTION study
    Rieke Alten
    Xavier Mariette
    Hanns-Martin Lorenz
    Hubert Nüßlein
    Mauro Galeazzi
    Federico Navarro
    Melanie Chartier
    Julia Heitzmann
    Coralie Poncet
    Christiane Rauch
    Manuela Le Bars
    [J]. Clinical Rheumatology, 2019, 38 : 1535 - 1535
  • [8] ADHERENCE TO THE RECOMMENDED DOSING REGIMEN OF ABATACEPT: RESULTS FROM THE INTERNATIONAL, REAL-WORLD ACTION STUDY
    Nuesslein, H.
    Alten, R.
    Galeazzi, M.
    Lorenz, H. M.
    Boumpas, D.
    Nurmohamed, M. T.
    Bensen, W. G.
    Burmester, G. R.
    Peter, H. -H.
    Rainer, F.
    Pavelka, K.
    Chartier, M.
    Poncet, C.
    Rauch, C.
    Le Bars, M.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 453 - 453
  • [9] Adherence to the recommended dosing regimen of abatacept: results from the international, real-world ACTION study
    Nuesslein, H.
    Alten, R.
    Galeazzi, M.
    Lorenz, H.
    Boumpas, D.
    Nurmohamed, M.
    Bensen, W.
    Burmester, G.
    Peter, H.
    Rainer, F.
    Pavelak, K.
    Chartier, M.
    Poncet, C.
    Rauch, C.
    LeBars, M.
    [J]. ZEITSCHRIFT FUR RHEUMATOLOGIE, 2013, 72 : 102 - 103
  • [10] RETENTION RATES AND CLINICAL OUTCOMES IN COHORTS OF PATIENTS (BIOLOGIC NAIVE OR FAILED PRIOR BIOLOGICS) TREATED WITH INTRAVENOUS ABATACEPT IN A REAL-WORLD SETTING: 6-MONTH RESULTS FROM THE ACTION STUDY
    Alten, R.
    Nuesslein, H.
    Galeazzi, M.
    Lorenz, H. -M.
    Mariette, X.
    Cantagrel, A.
    Chartier, M.
    Poncet, C.
    Rauch, C.
    Le Bars, M.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 1056 - 1057
12345